Open AccessEfficacy and tolerability of rilmenidine and its combination with amlodipine in different ages (according to ALTAIR study)
Author(s) -
E. V. Shalyakhto,
A. Ο. Conrady
Publication year - 2006
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2006-12-3-252-255
Subject(s) - rilmenidine , tolerability , amlodipine , medicine , blood pressure , pharmacology , imidazoline receptor , population , anesthesia , adverse effect , agonist , receptor , environmental health
The aim of the study was to evaluate efficacy and tolerance of rilmenidine and its combination with amlodipine in different age groups from ALTAIR study population. Rilmenidine therapy resulted insignificant reduction of blood pressure in all ages as well as had good tolerability. In conclusion, analysis of ALTAIR data indicates that Imidazoline agonists, in particular rilmenidine, can be administrated for hypertension treatment in patients of all ages.